Navigation Links
Aethlon Medical to Present at Today's Security Research Associates 8th Annual Growth Conference
Date:5/15/2012

SAN DIEGO, May 15, 2012 /PRNewswire/ -- Aethlon Medical, Inc. (OTCBB: AEMD), announced that Chairman and CEO James A. Joyce will present at today's Security Research Associates (SRA) 8th Annual Growth Stock Conference.  The Conference will be held at the Le Meriden Hotel in San Francisco.  A live webcast of the presentation will begin at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) and can be accessed online at: http://wsw.com/webcast/sra13/aemd/

(Photo: http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b)

The webcast and archived replay of the company's presentation may be accessed in the Investor Relations section of the Company's website at www.aethlonmedical.com.

About Aethlon Medical

The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with DARPA that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.

Contacts:

James A. Joyce
Chairman and CEO
858.459.7800 x301
jj@aethlonmedical.com

Jim Frakes
Chief Financial Officer
858.459.7800 x300
jfrakes@aethlonmedical.com

Marc Robins
877.276.2467
mr@aethlonmedical.com


'/>"/>
SOURCE Aethlon Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Aethlon Medical Reports Undetectable Hepatitis C Virus (HCV) in Genotype 1, Genotype 3, and Genotype 5 Patients Treated with Hemopurifier® Therapy
2. Aethlon Medical Note: Fiscal Year Revenue Guidance
3. Aethlon Medical Note: Marc Robins Joins the Aethlon Team
4. Aethlon Medical Note: An Unprecedented Data Point, The Single-Treatment Capture of Hepatitis C Virus (HCV) by the Aethlon Hemopurifier®
5. Aethlon Medical Reports Immediate and Rapid Virologic Responses in Hepatitis C (HCV) Patients Receiving Hemopurifier® Treatment Protocol
6. Aethlon Medical Establishes Sepsis & Inflammation Scientific Advisory Board
7. Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation
8. Aethlon Medical Announces Biotech Showcase™ 2012 Presentation
9. Aethlon Medical Announces Approval and Initiation of Cancer Research Study to Target Tumor-Secreted Exosomes
10. Aethlon Medical Releases Shareholder Letter
11. Aethlon Medical to Present at IN3 Medical Innovation Summit on October 27th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/7/2018)... ... August 07, 2018 , ... Commissioner Gottlieb’s FDA:, Analysis of First ... – 3:00 p.m. ET, http://www.fdanews.com/commissionergottliebsfda , Under Commissioner Scott Gottlieb, changes ... have benefited, some may have gotten hurt. , And Gottlieb is just getting started. ...
(Date:8/7/2018)... ... August 07, 2018 , ... Braun Ambulances is honored to announce their attendance ... Convention Center in Dallas, Texas. Braun Ambulances will have four units on display at ... , Fire Rescue International (FRI) is the International Association of Fire Chiefs’ (IAFC) annual ...
(Date:8/7/2018)... RAPIDS, Mich. (PRWEB) , ... August 07, 2018 ... ... the addition of Joe Morehouse, DO, to its growing team of eye care ... implants for astigmatism, and traditional intraocular lenses, as well as treating patients for ...
Breaking Medicine Technology:
(Date:8/9/2018)... ... August 09, 2018 , ... Thousands of US women with ... cross-referenced data from The American Society of Plastic Surgeons (ASPS), The American Society ... the FDA. As an MRI is recommended by FDA after the first three ...
(Date:8/9/2018)... Calif. (PRWEB) , ... August 09, 2018 , ... ... announces LegitScript certification. LegitScript is a new verification process that substance abuse providers ... “Being LegitScript certified means we can reach more people to help.” , ...
(Date:8/9/2018)... ... 09, 2018 , ... RiverGlade Capital (“RiverGlade”), is pleased to ... have an exclusive relationship with the firm. As an Operating Partner, Mr. ... sourcing, and deal origination, evaluation and diligence. He brings a wealth of ...
(Date:8/7/2018)... ... 07, 2018 , ... Josh Sprague, Founder and CEO of athletic goods company ... upcoming Leadville 100 MTB. , Accompanied by colleague Marvin Sandoval and equipped with ... “one of the most iconic mountain bike race courses in the world.” , ...
(Date:8/7/2018)... ... August 07, 2018 , ... ... line of Nancy’s Probiotic Foods. These rich, cream-on-top-style yogurts are made with milk ... yielding milk that's high in omega-3 fatty acids. Nancy’s sources the milk from ...
Breaking Medicine News(10 mins):